Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival.
about
Clinical management of filovirus-infected patientsPre-symptomatic diagnosis and treatment of filovirus diseasesEbola Virus Disease: Focus on ChildrenEmerging and Zoonotic Infections in WomenNeutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against itEbolavirus glycoprotein structure and mechanism of entryEarly immune responses accompanying human asymptomatic Ebola infectionsProduction of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal CattleEbola virus can be effectively neutralized by antibody produced in natural human infection.A seroepidemiologic study of Reston ebolavirus in swine in the PhilippinesPassive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda.Viral hemorrhagic fever hazards for travelers in Africa.Ebola virus disease: an update for anesthesiologists and intensivists.The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field.Cultural contexts of Ebola in northern Uganda.Clinical illness and outcomes in patients with Ebola in Sierra Leone.A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-makingAnti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs.Ebola virus disease in the Democratic Republic of the Congo, 1976-2014Ebola haemorrhagic fever among hospitalised children and adolescents in northern Uganda: epidemiologic and clinical observations.Ebola virus disease.Ebola Virus Disease, Democratic Republic of the Congo, 2014.Comparative study between Ribavirin and Ribavirin plus Intravenous Immunoglobulin against Crimean Congo hemorrhagic fever.Ebola Virus Disease in Children, Sierra Leone, 2014-2015.Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra LeoneAssessment of the severity of Ebola virus disease in Sierra Leone in 2014-2015Clinical Laboratory Values as Early Indicators of Ebola Virus Infection in Nonhuman Primates.The outbreak and control of Ebola viral haemorrhagic fever in a Ugandan medical school.Viewpoint: filovirus haemorrhagic fever outbreaks: much ado about nothing?Therapeutics for postexposure treatment of Ebola virus infection.Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody.Considerations for use of Ebola vaccine during an emergency response.Repurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic Review.Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates.Understanding bleeding in ebola virus disease.Incubation period of ebola hemorrhagic virus subtype zaire.Aerosol exposure to the angola strain of marburg virus causes lethal viral hemorrhagic Fever in cynomolgus macaques.The 2014-2015 Ebola saga: lessons for the future.
P2860
Q22305518-A0F70743-A206-489E-96FC-CA7E2CB33346Q26823831-C3133D12-0A70-462C-81AC-E5BEED7DCEB2Q26824080-D5DFDC93-A2AB-44DB-A345-BB2E281CE541Q27487976-602CD9C6-C7AA-4A3D-9FB0-488EBECEC24FQ27489891-5A8AE82A-30E6-4929-B5FE-18900D8808A3Q27490991-75D8F686-4D59-4964-8E7B-FB80AC3F788EQ28344889-C11CDB50-F43E-4299-B322-FD21D3671A3FQ28603849-174E784A-F8A0-4B9A-B061-A10CBCECBEE3Q30712477-69E22AEB-E9B9-4BF3-A4CC-6E908C91EEA7Q31065625-7FB483FE-D4A0-41D2-AA80-9E5AB76A3E08Q33840716-F993FF6F-409B-4363-9563-1858F8270CC5Q34152759-76C307D6-EABF-4FC5-A292-7067697FB000Q34398543-5EA176D4-48B9-4C4B-BD31-841A8F1FDF2FQ34446478-BD8CB433-F914-46B5-B239-C6C1BE45F9B4Q34489055-A196D199-DF31-4535-9570-25725D7570BFQ34549145-B7772C05-3061-4E9E-9118-EBED26279DE7Q35053891-67B7E900-185A-471B-938B-25C44CCD8F8CQ35646993-5C63610A-EF65-4E5C-BD8F-C8E3CFDC6812Q36046633-E129133E-9BBC-4AE9-B0F3-9D9F942FF55EQ36238123-7AD39DF4-B5D8-41ED-8898-465BDAF1FB66Q36276137-B3FB05EC-69CD-4C59-BEF0-82504D53C846Q36449434-263FCAB8-AE25-41DE-9092-03F9C01A22EDQ37196279-63314C85-A93D-497B-B1AA-81FB75FF7F4FQ37282815-30EA8D5B-17DD-4084-8C1B-44F1970327F0Q37288197-D85D9314-AF3C-43EF-8A0C-10FB3B2AB352Q37391098-24B7272D-78F7-498D-BD04-BB63EC512C29Q38408846-A191F5E7-444D-4A97-8057-5662A62682D4Q38670721-89DC33BB-7B0C-4EE3-9619-29B1251BAD76Q38884439-85F2E2AA-79FC-4D72-ACBA-39A5D1BBF683Q38914896-82117A20-F04D-49AB-AF3E-DA4BBC6798E2Q38980947-D0DBC4A7-F5A1-4BDC-B342-A500B79C3958Q39683688-0EA46A6A-D985-4838-9CCA-6CA7651D6BA2Q40039769-9CC2344A-C399-4980-90B3-44E9EF62E746Q40045378-C3BFD5BE-D8C3-496C-9788-B6F30928029BQ40091054-8BBD49E0-00FD-4803-821D-EC9E6F9042E0Q40169485-C15D10A3-0635-49CE-81D8-45B3B77F6F19Q40323330-911232BB-3EA8-4A33-B370-06FB7264C7EBQ40349753-D118D824-C151-4E05-B361-6418F57EF886Q44100284-6CF6D22D-CFE2-4C19-80C1-3ADAEB5F74C2
P2860
Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Ebola hemorrhagic fever, Democ ...... 995: determinants of survival.
@en
Ebola hemorrhagic fever, Democ ...... 995: determinants of survival.
@nl
type
label
Ebola hemorrhagic fever, Democ ...... 995: determinants of survival.
@en
Ebola hemorrhagic fever, Democ ...... 995: determinants of survival.
@nl
prefLabel
Ebola hemorrhagic fever, Democ ...... 995: determinants of survival.
@en
Ebola hemorrhagic fever, Democ ...... 995: determinants of survival.
@nl
P2093
P921
P356
P1476
Ebola hemorrhagic fever, Democ ...... 995: determinants of survival.
@en
P2093
P356
10.1086/514311
P407
P478
179 Suppl 1
P577
1999-02-01T00:00:00Z